Cargando…
Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
Although β-amyloid (Aβ) may be the primary driver of Alzheimer’s disease (AD) pathology, accumulation of pathological tau correlates with dementia in AD patients. Thus, the prevention/inhibition of AD may require vaccine/s targeting Aβ and tau simultaneously or sequentially. Since high antibody tite...
Autores principales: | Davtyan, Hayk, Zagorski, Karen, Rajapaksha, Harinda, Hovakimyan, Armine, Davtyan, Arpine, Petrushina, Irina, Kazarian, Konstantin, Cribbs, David H., Petrovsky, Nikolai, Agadjanyan, Michael G., Ghochikyan, Anahit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929459/ https://www.ncbi.nlm.nih.gov/pubmed/27363809 http://dx.doi.org/10.1038/srep28912 |
Ejemplares similares
-
Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein
por: Zagorski, Karen, et al.
Publicado: (2022) -
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice
por: Davtyan, Hayk, et al.
Publicado: (2019) -
A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice
por: Hovakimyan, Armine, et al.
Publicado: (2019) -
Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
por: Hovakimyan, Armine, et al.
Publicado: (2022) -
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2022)